What is the recommended enhanced recovery after surgery (ERAS) pathway for an adult patient undergoing neck dissection?

Enhanced Recovery After Surgery (ERAS) for Neck Dissection

While no specific ERAS guidelines exist exclusively for neck dissection, implement a comprehensive ERAS pathway adapted from head and neck oncologic surgery protocols, which have demonstrated feasibility and significant reductions in hospital length of stay without increasing readmission rates. 1, 2, 3, 4

Core ERAS Elements for Neck Dissection

Preoperative Phase

Patient Education & Counseling

• Provide structured preoperative education including written materials and video content explaining the ERAS pathway, expected recovery timeline, and discharge criteria 5, 1
• Use patient diaries to track recovery milestones 1
• Implement electronic health platforms when available to increase patient engagement and compliance 6

Nutritional Optimization

• Screen all patients for malnutrition using validated tools (NRS scoring system) 7
• For malnourished patients: initiate oral nutritional supplements 7-10 days preoperatively to reduce infectious complications and anastomotic leaks 7
• For well-nourished patients: encourage normal diet until midnight before surgery 5, 7

Medical Optimization

• Screen and treat anemia if time permits 6
• Mandate smoking cessation and alcohol abstinence for 4 weeks preoperatively (associated with reduced respiratory, wound, and infectious complications) 6
• Optimize comorbidities including hypertension, diabetes, and cardiac conditions 8

Preoperative Fasting & Carbohydrate Loading

• Clear liquids until 2 hours before surgery 5, 7
• Administer 300ml isotonic beverage containing 50g maltodextrin, finished 2 hours before surgery 5
• Normal diet permitted until midnight 5, 7

Intraoperative Phase

Anesthetic Management

• Preemptive analgesia: 300mg celecoxib + 500mg acetaminophen orally in pre-op 5
• Anesthesia protocol: Continuous propofol, intravenous lidocaine, and low-dose ketamine infusion; avoid volatile anesthesia 5
• Anti-emetic prophylaxis: 4mg ondansetron + 8mg dexamethasone IV prior to emergence 5

Surgical Considerations

• Avoid tracheostomy when clinically feasible 1
• Implement goal-directed fluid therapy using standardized algorithms targeting blood pressure, cardiac index, and urine output (reduces complications and length of stay) 6
• Maintain patient normothermia using forced warm air and IV fluid warmers 5

Fluid Management

• Restrictive approach: 0.5ml/kg/h for 6 hours postoperatively 5
• Use goal-directed protocols rather than liberal fluid administration 6

Postoperative Phase

Pain Management (Multimodal Approach)

• Local anesthesia: 0.25% liposomal bupivacaine wound infiltration 5
• Standing medications:
  • Acetaminophen 500mg every 6 hours orally 5
  • Ibuprofen 600mg every 6 hours orally 5
• Opioid minimization strategy (escalating as needed):
  1. Tramadol 25mg every 6 hours orally as needed
  2. Increase to tramadol 50mg if inadequate
  3. Add IV lidocaine infusion
  4. Add pregabalin 100-300mg every 8 hours
  5. Oxycodone 5-10mg orally for breakthrough pain only 5

Drain and Line Management

• Remove Foley catheter in OR or immediately postoperatively 5, 9
• Minimize surgical drain use when safe 5

Early Mobilization

• Ambulate to chair in PACU 5
• Ambulate 3 times starting postoperative day 0 5
• Out of bed for all meals 5
• Minimum 8 hours out of bed daily starting postoperative day 1 5
• Target: 2 hours out of bed on day of surgery, 6 hours daily thereafter 9

Nutrition Management

• Begin clear liquids on postoperative day 0 5
• Advance to regular diet beginning postoperative day 1 5
• Early enteral nutrition is safe and promotes recovery 7
• Target minimum 2000ml oral intake daily for discharge 5

Bowel Regimen

• Standing MiraLax daily beginning postoperative day 0 5

Discharge Criteria

Patients must meet ALL of the following:

• Tolerating at least 2000ml oral intake daily 5
• Voiding independently 5
• Pain well controlled on oral medications 5
• Ambulating independently in hallways 5

Post-Discharge Management

• Contact patients through daily email surveys or phone calls 5
• Monitor for complications requiring readmission
• Continue nutritional supplements if prescribed preoperatively 7

Evidence for ERAS in Head and Neck Surgery

The evidence strongly supports ERAS implementation in head and neck oncologic surgery, with multiple studies demonstrating:

• Reduced hospital length of stay: Decreased from 9 days to 6 days for oral cavity procedures, and from 6 days to 3 days for cutaneous/lateral skull base reconstruction 3
• Fewer ICU admissions: 4% vs 14% in control groups 4
• Reduced complications: 18.6% vs 27.0% in traditional care 4
• No increase in readmission rates: 10.3% vs 10.5% pre-ERAS 3
• Decreased opioid requirements: 138.8 vs 207.9 morphine milligram equivalents over 72 hours 4
• Reduced discharge to skilled nursing facilities: 9.2% vs 24% pre-ERAS 3

Implementation Considerations

Critical success factors include:

• Multidisciplinary team engagement (surgeons, anesthesiologists, nurses, dieticians, physical therapists, speech therapists) 1, 2
• Designated ERAS champions and nurse coordinators 6
• Electronic medical record integration for compliance tracking 2
• Systematic audit of compliance and outcomes 9

Common pitfalls to avoid:

• Low compliance with preoperative education (only 55% in some series) 1
• Inadequate early mobilization (only 7-57% compliance reported) 1, 2
• Failure to implement goal-directed fluid therapy (only 10% compliance in some studies) 1
• Inconsistent tracking of patient-reported outcomes 2

Target compliance rate: Aim for >75% adherence to protocol elements, as compliance correlates linearly with improved outcomes 9

The meta-analysis of ERAS across all surgical specialties demonstrates mean hospital stay reduction of 1.88 days (95% CI 0.95-2.81 days) with decreased complications (RR 0.71,95% CI 0.59-0.87) 10, supporting aggressive implementation of these protocols in neck dissection surgery.